midi health glp 1 reviews GLP-1 medications are rapidly expanding beyond their role in diabetes and obesity management, with emerging evidence pointing to potential benefits in cardiovascular health, inflammation, neuroprotection, addiction, and more. Join us for a Midi Health vs Ro: Clinical

Nearly one-fifth of people, 19%, report that they have used a GLP-1 medication before

When compared to dulaglutide and placebo, tirzepatide statistically significantly displayed improvement in ALT and AST from baseline

Smarter weight-loss treatment, personalized for you

If required, this can be further adjusted up to 1 mg and ultimately 2mg (the maximum dose for diabetes treatment) weekly

A Master Protocol to Investigate the Efficacy and Safety of LY3437943 in Participants Without Type 2 Diabetes Who Have Obesity or Overweight (includes OSA + knee OA substudies)

Participants then increase their dose gradually, usually every four weeks, until they reach the target dose being studied